Advertisement
GSK plc

GSK plc (GSK) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

GSKNYSE
HealthcareDrug Manufacturers - General
$53.04
$0.18(0.34%)
U.S. Market opens in 61h 20m
Advertisement

GSK plc (GSK)

Meyka AI Score

Z

Key Financials

Market Cap106.3B
P/E Ratio13.72
EPS (TTM)$3.79
ROE0.28%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

GSK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.72 and a market capitalization of 106.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.31%
5-Day Change
3.12%
1-Month Change
4.17%
3-Month Change
-2.31%
6-Month Change
8.64%
Year-to-Date (YTD) Change
8.13%
1-Year Change
24.79%
3-Year Change
54.19%
5-Year Change
30.96%
All-Time (Max) Change
7980.00%

Contact Information

44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

686,290 Employees
IPO DateMar 28, 1980
CountryGB
Actively Trading

Frequently Asked Questions